Julie Marie Eastland

Harpoon Therapeutics, Inc.

Julie M. Eastland, serves as the President, CEO and board member at Harpoon Therapeutics, Inc. She was previously COO and and CFO at Recode Therapeutics, Inc. since 2020. She has expertise in professional and corporate industries, specializing in developing and implementing strategic plans into operational successes. Julie serves as a Director of Dynavax Technologies Corp. and Graybug Vision, Inc. She previously served as Independent Director of Pascal Biosciences Inc. and a director of CG Therapeutics, Inc. She holds an MBA from Heriot-Watt University of the Edinburgh University Management School and a B.S. in finance from the Colorado State University.

Year appointed: 2021

Register for this year’s Action for Impact Summit happening on September 25, 2024!